Ivan Iglesias-Baena

Dr. Ivan Iglesias-Baena

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
FAFrancisco Andujar-Vera
Francisco Andujar-Vera
MAMaría Luisa Alés-Palmer
María Luisa Alés-Palmer
PMPaloma Muñoz-De-Rueda
Paloma Muñoz-De-Rueda
IIIvan Iglesias-Baena
Ivan Iglesias-Baena
EOEsther Ocete-Hita
Esther Ocete-Hita
Hepatotoxicity, a common adverse drug effect, has been extensively studied in adult patients. However, it is equally important to investigate this condition in pediatric patients to develop personalized treatment strategies for children. This study aimed to identify plasma biomarkers that characterize hepatotoxicity in pediatric patients through an observational case–control study. Metabolomic analysis was conducted on 55 pediatric patients with xenobiotic liver toxicity and 88 healthy controls. The results revealed clear differences between the two groups. Several metabolites, including hydroxydecanoylcarnitine, octanoylcarnitine, lysophosphatidylcholine, glycocholic acid, and taurocholic acid, were identified as potential biomarkers (area under the curve: 0.817; 95% confidence interval: 0.696–0.913). Pathway analysis indicated involvement of primary bile acid biosynthesis and the metabolism of taurine and hypotaurine (p < 0.05). The findings from untargeted metabolomic analysis demonstrated an increase in bile acids in children with hepatotoxicity. The accumulation of cytotoxic bile acids should be further investigated to elucidate the role of these metabolites in drug-induced liver injury.

11 June 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
MAMaría Luisa Alés-Palmer
María Luisa Alés-Palmer
FAFrancisco Andujar-Vera
Francisco Andujar-Vera
IIIvan Iglesias-Baena
Ivan Iglesias-Baena
PMPaloma Muñoz-De-Rueda
Paloma Muñoz-De-Rueda
EOEsther Ocete-Hita
Esther Ocete-Hita
Idiosyncratic drug-induced liver injury (DILI) is a complex multifactorial disease in which the toxic potential of the drug, together with genetic and acquired factors and deficiencies in adaptive processes, which limit the extent of damage, may determine susceptibility and make individuals unique in their development of hepatotoxicity. In our study, we sequenced the exomes of 43 pediatric patients diagnosed with DILI to identify important gene variations associated with this pathology. The result showed the presence of two variations in the NAT2 gene: c.590G>A (p.Arg197Gln) and c.341T>C (p.Ile114Thr). These variations could be found separately or together in 41 of the 43 patients studied. The presence of these variations as a risk factor for DILI could confirm the importance of the acetylation pathway in drug metabolism.